Summit Therapeutics surged by 16.05 percent on Wednesday to close at $28.27 apiece, leading the rally of the overall ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Indian retail investors ramped up US stock purchases amid global market volatility, with a strong tilt toward semiconductors, ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

PepsiCo reports 4% organic revenue growth in its international snacks business in Q2 2025, driven by strong performance in ...

PepsiCo reported a 4% growth in its global snacks business in Q2 2025, driven by strong performance in markets like India.

The Australian Dollar (AUD) quickly reversed Wednesday’s optimism vs. the US Dollar (USD), sending AUD/USD back below the key ...

Capital importation into Nigeria witnessed a sharp decline during the eight-year administration of former President Muhammadu ...

PepsiCo said that the snacks business saw “good performance” in markets like India in the second quarter of CY2025. The ...

Stocks are climbing today on signs the US economy is holding up, despite tariff uncertainty. Positive economic news today ...

The firm saw growth in its core laboratory segment but declines in molecular, point of care, and rapid diagnostics.

In the early hours of trading, the Dow Jones Industrial Average (.DJI), opens new tab rose 40.95 points, or 0.09%, to ...